The peptide activates mTOR, which phosphorylates ribosomal protein S6 kinase to accelerate protein synthesis, but without progressive resistance training to create muscle damage and satellite cell recruitment, there is minimal substrate for growth
Reliability to operate Create certainty and peace of mind for operators, production managers, and management with transparent information available to all
Research shows Sermorelins natural growth hormone stimulation minimizes the risk of joint pain, insulin resistance and other complications associated with supraphysiological hormone levels
Topical evidence is stronger and includes IRB-approved human trials
Serious adverse effects (SAEs) were reported in two (3.08%, chest pain and lumbar spinal stenosis) and one patient (1.52%, spinal osteoarthritis) in the Met+Sita and Met+Sita+Acarb group, respectively
In the REDEFINE 1 phase 3 trial, cagrilintide 2.4 mg monotherapy produced an average body weight reduction of 11.8% over 68 weeks